Technical Agreement for Distribution Services
1. Contracting
Parties
Contract
Giver:
|
Gentium
S.p.A
|
|
Name
and Address:
|
Xxxxxx
XX Xxxxxxxxx, 0
|
|
00000
Xxxxx Xxxxxxx, Xxxx
|
||
Xxxxx
|
(Hereafter
referred to as "Gentium")
Contract
Acceptor:
|
IDIS
Limited
|
|
Name
and Address:
|
XXXX
Xxxxx
|
|
Xxxxxxxxxxx
Xxxx
|
||
Xxxxxxxxx
|
||
Xxxxxx
|
||
XX00
0XX
|
||
Xxxxxx
Xxxxxxx
|
(Hereafter
referred to as "IDIS")
Terms
used but not defined herein shall have the meanings given to them in the Supply
and Distribution Agreement.
2. Changes
to this Agreement
2.1.
|
All changes to this agreement must be agreed by both parties following written submission by the requesting party. |
No
|
Details
of changes / Reason
|
Date
|
1.
|
||
2.
|
||
3.
|
3. Purpose
of the Agreement
3.1.
|
The
purpose of this agreement is to describe the technical aspects of the
storage and the distribution of certain finished products of Gentium
carried out by IDIS.
|
3.2.
|
The
regulations of this agreement apply to all orders referring to the product
list (see Schedule 1), which have been agreed upon signing the Technical
Agreement and before the notice has taken effect. They also apply to
orders, which have already been given to IDIS on behalf of Gentium, as
long as they have not yet been carried
out.
|
3.3.
|
Gentium
is responsible for marketing the
product.
|
4.
|
Basis
|
4.1.
|
IDIS
shall comply with the legal regulations that apply to its area of
responsibility.
|
4.2.
|
IDIS
is in the possession of a valid wholesale dealer’s license issued by the
UK Medicines and Healthcare Products Regulatory Agency. IDIS shall
maintain its systems to support its license. In the event that IDIS loses,
or is at risk of losing its wholesaler dealer’s license IDIS shall
immediately notify Gentium.
|
4.3.
|
Gentium
and IDIS appoint responsible contact persons (refer to
Schedule 2).
|
Both
must inform each other of every amendment to the agreement in writing.
Amendments are also part of this
agreement.
|
4.4.
|
IDIS
shall implement and update an effective quality management system (QMS),
including the performance of internal audits and the implementation of the
resulting corrective actions.
|
4.5.
|
IDIS
shall ensure that all staff affected by this agreement shall be
appropriately trained with the valid standard operating procedures (SOP)
and further regulations of Gentium and incorporating any necessary
amendments into IDIS SOPs which are validated by
Gentium.
|
4.6.
|
IDIS
shall allow the responsible persons of Gentium to carry out quality
assurance audits providing reasonable notice has been
given.
|
4.6.1.
|
These
audits shall be limited in scope to the area’s and systems directly
related to Gentium’s product.
|
5.
|
Responsibilities
|
5.1.
|
Gentium
is responsible for:
|
5.1.1.
|
Ensuring
product and packaging elements meet Italian regulatory
requirements.
|
5.1.2.
|
Providing
IDIS with information relevant for the correct product
handling
|
5.1.2.1. All
packaging shall reflect Gentium livery.
5.1.3.
|
Making
sure that the manufacturer is appropriately
licensed.
|
5.2.
|
IDIS
is responsible for:
|
5.2.1.
|
Complying
with the cGDP (current Good Distribution Practices) guidelines and
ensuring that the correct products are delivered to the consignee at the
right time
|
5.2.2.
|
A
GDP compliant handling of the returned
products
|
5.2.3.
|
Implementing
an effective system for Recall
|
5.2.4.
|
Performing
visual inspection on received goods (e.g. integrity of shipment
containers, completeness of shipment against shipment documents
etc.)
|
5.2.5.
|
IDIS
shall inform Gentium of any negative quality or safety issues regarding
Gentium products should they become aware of
any.
|
5.2.6.
|
Additional
activities/requirements as defined in the ‘Supply and Distribution
Agreement’: maintenance of the named patient program database, processes
of a controlled distribution, and aspects with regard to drug
safety
|
5.2.7.
|
Managing
drug in line with the process flow in schedule
4
|
5.2.8.
|
Reporting
any received adverse events notifications to Gentium in accordance with
the process detailed in schedule 5
|
6.
|
Facilities
|
6.1.
|
IDIS
shall manage the warehouse in accordance with GDP as well as storing
the Gentium products delivered on
behalf of Gentium duly.
|
6.2.
|
IDIS
shall protect the Gentium products from damaging impacts and from access
by unauthorized persons.
|
Damaging
impacts include but are not limited to:
|
|
-
damaging variations in temperature and humidity
|
|
-
dust and smell
|
|
-
animals, insects
|
6.3.
|
IDIS
shall inform Gentium immediately if Gentium products become visibly
damaged or risk getting visibly
damaged.
|
6.4.
|
IDIS
shall maintain the storage rooms and facilities in accordance with GDP and
to calibrating measuring instruments (e.g. temperature/humidity loggers)
on a regular basis in accordance with
GDP.
|
6.5.
|
IDIS
shall keep the storage rooms in an orderly and tidy condition. Cleaning is
done following a written cleaning
program.
|
6.6.
|
IDIS
shall appoint reliable personnel for the distribution orders, having the
required theoretical and technical
qualifications.
|
6.7.
|
IDIS
shall obtain written approval from Gentium if the stored goods are
transferred into another warehouse other than the one in Xxxx 0,Xxxxxx
Xxxx, Xxxxxxx, Xxxxxx, Xxxxxx Xxxxxxx. The same applies to changes of
locations or any change within the warehouse, which may affect the
storage, and handling of the
products.
|
7.
|
Product
Data
|
7.1.
|
Gentium
shall forward IDIS the relevant product data necessary for carrying out
the tasks well in advance and for keeping IDIS updated with current
product information should there be any changes or
amendments
|
7.2.
|
IDIS
shall maintain product related data in line with regulatory
requirements.
|
8.
|
Storage,
Delivery and Transportation
|
8.1.
|
The
handling of processes is defined in the existing QMS of IDIS based on
SOPs. These are:
|
8.1.1.
|
Incoming
goods: Quarantine, release,
documentation
|
8.1.2.
|
Handling
of quality deficiencies
|
8.1.3.
|
Incoming
and outgoing of goods: According to the FEFO principle (first expiry -
first out), or the FIFO principle (first in - first out),
respectively
|
8.1.4.
|
Commissioning
and distribution of products
|
8.1.5.
|
Recall
procedures
|
8.1.6.
|
Destruction
of damaged or expired goods
|
8.1.7.
|
Drug
safety procedures
|
8.1.8.
|
Complaint
handling
|
9.
|
Duty
of Information
|
9.1.
|
IDIS
must immediately inform Gentium if:
|
9.1.1.
|
An
inspection by an authority regarding the contracting products is
announced
|
9.1.2.
|
Measures
are taken by competent authorities regarding Gentium
products.
|
9.1.3.
|
IDIS
learns about a serious product safety, quality of efficacy
problem/issue
|
9.2.
|
Gentium
must inform IDIS of the supply chain details e.g. site of manufacturer,
packaging/assembly, storage prior to product arriving at IDIS. This shall
be listed in Schedule 3
|
9.3.
|
Gentium
shall provide IDIS with copies of licenses held by Gentium nominated
manufacturer, packaging/assembly site or storage
site.
|
10.
|
Confidentiality
|
10.1
|
Information
shared by either party concerning the Products will remain confidential in
accordance with the Confidentiality Agreement and Supply and Distribution
Agreement, which shall survive termination of this
Agreement.
|
11.
|
Quality
Control
|
11.1.
|
Gentium
shall be responsible for full product testing in accordance with
their internal procedures, specifications, methods
of analysis and any relevant Marketing Authorisation of the Products
detailed in Schedule 1.
|
11.2.
|
Gentium
shall be responsible for forwarding a Certificate of Analysis for each
batch to IDIS.
|
11.3.
|
Gentium shall be responsible for forwarding a
Certificate of Compliance for each
batch to IDIS.
|
12.
|
Sub
Contracting
|
12.1.
|
With
the exception of courier services, IDIS shall not subcontract any
activities of the product without prior consent of
Gentium.
|
13.
|
Table
of Responsibilities
|
13.1.
|
Responsibilities
|
GENTIUM
|
IDIS
|
1
|
Adverse
event notification
|
X
|
13.2.
|
Product
Data & Quality Control
|
GENTIUM
|
IDIS
|
1
|
Transmission
of product-related logistic
|
X
|
|
2
|
Correct
handover and maintenance of product data
|
X
|
X
|
3
|
Provide
TSE Certification regarding product status to IDIS
|
X
|
|
4
|
Provide
Certificate of Analysis for each product batch
|
X
|
|
5
|
Provide
Certificate of Compliance for each product batch
|
X
|
13.3.
|
Storage,
Delivery and Transportation
|
GENTIUM
|
IDIS
|
1
|
Delivery
of products in conformity with the local market as nominated by
Gentium
|
X
|
|
2
|
Determination
of the storage conditions and way of shipment
|
X
|
|
3
|
Adherence
to storage conditions and way of shipment to user
|
X
|
|
4
|
Compliance
with GDP guidelines
|
X
|
|
5
|
Handling
of returned goods
|
X
|
|
6
|
Handling
of technical product complaints
|
X
|
X
|
7
|
Recall
procedures
|
X
|
X
|
8
|
Incoming
goods, control, inventory update
|
X
|
X
|
9
|
Adherence
to FEFO principle
|
X
|
|
10
|
Shipments
of products
|
X
|
|
11
|
Destruction
of damaged, returned and expired goods
|
X
|
13.4.
|
Documentation
|
GENTIUM
|
IDIS
|
X
|
X
|
IN
WITNESS whereof this Agreement has been entered into the day and year
written.
SIGNED for and on behalf of
/s/ Xxxx
Xxxxxxxxx
Name:
Xxxx Xxxxxxxxx
Title: Executive
Vice President and Chief Financial Officer
Date:
February 26, 2009
SIGNED
for and on behalf of
IDIS
(TRADING AS IDIS LIMITED)
/s/ Xxxxx
Xxxxxxxxx
Name:
Xxxxx Xxxxxxxxx
Title: Responsible
Person
Date:
November 3, 2008
/s/ Xxxx
Xxxxx
Name: Xxxx
Xxxxx
Title: Operations
Director
Date:
November 6, 2008
Schedule
1 – Product List
Brand
Name:
Generic
Name: Defibrotide
Strength:
200mg
Presentation:
2.5ml ampoule
Form:
Solution
Storage:
Ambient
Pack
size: 10 x 2.5ml ampoules
Therapeutic
Area: Hematology-Oncology
Brand
Name: Prociclide
Generic
Name: Defibrotide
Strength:
400mg
Presentation: Blister
pack
Form: Capsule
Storage:
Ambient
Pack
size: 1 x 21
Therapeutic
Area:
Hematology-Oncology
Schedule
2 – Contact Persons
Contract
Acceptor
|
Contract
Giver
|
|
Simon
Estcourt
Director
– Global Market Access
XXXX
Xxxxx
Xxxxxxxxxxx
Xxxx
Xxxxxxxxx
Xxxxxx
XX00
0XX
Xxxxxx
Xxxxxxx
Telephone
No: 00000 000000
Fax
No: 00000 000000
|
Xxx
Xxxxxxx
00
Xxxxxxxxxxx Xxxxx
Xxxxx
0000
Xxx
Xxxx, XX 00000
Telephone
No: 000-000-0000
E-mail
Address: xxxxxxxx@xxxxxxx.xxx
|
|
Xxxxx
Xxxxxxxxx
Responsible
Person
At
above address
Direct
Telephone No: 00000 000000
Email
address : xxxxxxxxxx@xxxxxxxxxx.xxx
|
Xxxx
Xxxxxxxxx
At
above address
Direct
Telephone No: 000-000-0000
Email
address: xxxxxxxxxx@xxxxxxx.xxx
|
|
Xxxxx
Xxxxxx
Supply
Chain Manager
At
above address
Direct
Telephone No: 00000 000000
Email
address: xxxxxxx@xxxxxxxxxx.xxx
|
Xxxxxxx
Xxxxxxxxx
Xxxxxx
XX Xxxxxxxxx
0,
00000 Xxxxx Xxxxxxx (Xxxx)
Xxxxx
Direct
Telephone No: x00 000 000 000
Email
address: xxxxxxxxxx@xxxxxxx.xx
|
|
Xxxxxxxxx
Xxxxxxxxx
At
above address
Direct
Telephone No: x00 000 000 000
Email
address: xxxxxxxxxx@xxxxxxx.xx
|
||
Xxxxxxxx
Xxxxx
At
above address
Direct
Telephone No: x00 000 000 000
Email
address:
xxxxxx@xxxxxxx.xx
|
Schedule
3 – Supply Chain Details
Site of
manufacturer: Villa Guardia (Co) Italy
Site of
packaging/assembly: Villa Guardia (Co) Italy
Site of
storage prior to product arriving at IDIS: Villa Guardia (Co)
Italy
Pack
dimensions:
Contact
for placement of purchase orders:
Xxxxxx
Xxxxxxx (xxxxxxx@xxxxxxx.xx)
x00 000 000 000
Xxxxxxxxx
Xxxxxxxxx (xxxxxxxxxx@xxxxxxx.xx)
x00 000 000 000
Xxxxxxx
Xxxxxxxx (xxxxxxxxx@xxxxxxx.xx)
x00 000 000 000
Xxxxxxx
Xxxxxxxxx (xxxxxxxxxx@xxxxxxx.xx) x00
000 000 000
Xxxxxxxx
Xxxxx (xxxxxx@xxxxxxx.xx) x00
000 000 000
Xxx
Xxxxxxx (xxxxxxxx@xxxxxxx.xxx) 212-332-1664
Xxxxxxx
Xxxxx (xxxxxx@xxxxxxx.xx)
x00 000 000 000
Product
lead-time from placement of purchase order: 90 days
Contact
for Invoicing:
Xxx
Xxxxxxx (xxxxxxxx@xxxxxxx.xxx) 212-332-1664
XXXXXXXXXXXXXXX@xxxxxxx.xx
x00 000 000 000
Contact
for provision of monthly sales report:
Xxxxxxx
Xxxxxxxx (xxxxxxxxx@xxxxxxx.xx)
x00 000 000 000
Xxxxxxx
Xxxxxxxxx (xxxxxxxxxx@xxxxxxx.xx) x00
000 000 000
Xxx
Xxxxxxx (xxxxxxxx@xxxxxxx.xxx) 212-332-1664
Xxxx
Xxxxxxxxx (xxxxxxxxxx@xxxxxxx.xxx) 000-000-0000
Xxxxxxxxx
Xxxxxxxx (xxxxxxxxx@xxxxxxx.xx)
x00 000 000 000
Xxxxxxxx
Xxxxx (xxxxxx@xxxxxxx.xx) x00
000 000 000
Schedule
4 – Process Flow
Schedule
5 – Pharmacovigilance
Gentium
Pharmacovigilance Representatives
Xxxxxxxxx
Xxxxxxxx, Ph.D.
Drug
Safety Manager,
Medical
Department
TEL:
x00.000.000.000
FAX:
x00.000.000.000
xxxxxxxxx@xxxxxxx.xx
Xxxxxxx
Xxxxxxxxx
Senior
Vice-President, Scientific Director
Tele: x00-000-000-000
Mobile: x00-000-000-0000
xxxxxxxxxx@xxxxxxx.xx
|
IDIS
Pharmacovigilance Representatives
Telephone
: x00 (0) 0000 000 000
Fax
: x00 (0) 0000 000 000 - FAO Technical Enquiries
Email
:
xx@xxxxxxxxxx.xxx
|
Schedule
6 – Access Form
Schedule
7 – Free of Charge Form